These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8091999)

  • 41. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent developments in expressed emotion and schizophrenia.
    Kavanagh DJ
    Br J Psychiatry; 1992 May; 160():601-20. PubMed ID: 1591571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
    Perkins DO; Johnson JL; Hamer RM; Zipursky RB; Keefe RS; Centorrhino F; Green AI; Glick IB; Kahn RS; Sharma T; Tohen M; McEvoy JP; Weiden PJ; Lieberman JA;
    Schizophr Res; 2006 Mar; 83(1):53-63. PubMed ID: 16529910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of social factors on the long-term course of schizophrenia].
    Ciompi L
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):101-13. PubMed ID: 6148786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP).
    Pelayo-Terán JM; Gajardo Galán VG; de la Ortiz-García de la Foz V; Martínez-García O; Tabarés-Seisdedos R; Crespo-Facorro B; Ayesa-Arriola R
    Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):315-323. PubMed ID: 27796500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Choosing antipsychotic maintenance therapy--a naturalistic study.
    Tavcar R; Dernovsek MZ; Zvan V
    Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Environmental interventions in schizophrenia. 1: The individual and the domestic levels.
    Warner R
    New Dir Ment Health Serv; 1999; (83):61-70. PubMed ID: 10495649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Behavioral concepts for the etiology of schizophrenia].
    Stieglitz RD; Vauth R
    Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S60-5. PubMed ID: 16270246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prodromal symptoms and relapse prevention in schizophrenia.
    Herz MI; Lamberti JS
    Schizophr Bull; 1995; 21(4):541-51. PubMed ID: 8749882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis.
    Gleeson JF; Cotton SM; Alvarez-Jimenez M; Wade D; Crisp K; Newman B; Spiliotacopoulos D; McGorry PD
    J Clin Psychiatry; 2010 Apr; 71(4):475-83. PubMed ID: 20021994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Family and patient predictors of symptomatic status in schizophrenia.
    Levene JE; Lancee W; Seeman MV; Skinner H; Freeman SJ
    Can J Psychiatry; 2009 Jul; 54(7):446-51. PubMed ID: 19660166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of life events on the subsequent course of psychotic illness. A prospective follow-up of the Camberwell Collaborative Psychosis Study.
    van Os J; Fahy TA; Bebbington P; Jones P; Wilkins S; Sham P; Russell A; Gilvarry K; Lewis S; Toone B
    Psychol Med; 1994 May; 24(2):503-13. PubMed ID: 8084944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emotion perception and overconfidence in errors under stress in psychosis.
    Köther U; Lincoln TM; Moritz S
    Psychiatry Res; 2018 Dec; 270():981-991. PubMed ID: 29685325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Life stress, coping and comorbid youth: an examination of the stress-vulnerability model for substance relapse.
    Anderson KG; Ramo DE; Brown SA
    J Psychoactive Drugs; 2006 Sep; 38(3):255-62. PubMed ID: 17165368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing relapse in the long-term course of schizophrenia.
    Ayuso-Gutiérrez JL; del Río Vega JM
    Schizophr Res; 1997 Dec; 28(2-3):199-206. PubMed ID: 9468354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient attributes and expressed emotion as risk factors for psychotic relapse.
    Linszen DH; Dingemans PM; Nugter MA; Van der Does AJ; Scholte WF; Lenior MA
    Schizophr Bull; 1997; 23(1):119-30. PubMed ID: 9050118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mood induced cognitive and emotional reactivity, life stress, and the prediction of depressive relapse.
    Lethbridge R; Allen NB
    Behav Res Ther; 2008 Oct; 46(10):1142-50. PubMed ID: 18707676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Nithsdale Schizophrenia Survey. VII. Does relatives' high expressed emotion predict relapse?
    McCreadie RG; Phillips K
    Br J Psychiatry; 1988 Apr; 152():477-81. PubMed ID: 3167397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A neural biomarker of psychological vulnerability to future life stress.
    Swartz JR; Knodt AR; Radtke SR; Hariri AR
    Neuron; 2015 Feb; 85(3):505-11. PubMed ID: 25654256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.